Cohen's lab develops genetically encoded fluorescent voltage indicators and all-optical electrophysiology ('Optopatch') to simultaneously stimulate and image membrane voltage in individual neurons and cardiomyocytes at the single-cell and network level, combining protein engineering, optics, and theory to push the temporal and spatial resolution of bioelectrical imaging well past conventional patch-clamp limits.

Garrido is a computational cognitive neuroscientist — predictive coding, Bayesian brain models, neuroimaging biomarkers for mental health — who was appointed a chief investigator of the ARC Centre of Excellence in Quantum Biotechnology specifically to work with the Melbourne and UQ physics groups on non-invasive quantum-sensor recording of human brain magnetic fields. She is the human-subject and source-reconstruction end of the QUBIC portable-brain-imager programme: her lab supplies the paradigms, the clinical cohorts and the inverse-problem modelling that a diamond- or OPM-based MEG system has to serve. Positioned against the established body of NV-ensemble quantum sensing work — DEER, nanoscale NMR and T1 relaxometry protocols operating at pT/sqrt(Hz) field sensitivity — she is not a sensor developer, but she is the reason the pT/sqrt(Hz)-class magnetometers being built at Melbourne have a human-trials pathway at all. Preferred attributes present in strength: bioelectromagnetism and human trials with novel quantum technologies. Included as a deliberate borderline case — a sensing postdoc would be the physics half of a collaboration with this lab, not a member of it.